JAK inhibitor CHZ868, Purity ≥98%

Synonym: CHZ868; 1895895-38-1; CHZ-868; N-[4-[2-(2,4-Difluoroanilino)-1,4-dimethylbenzimidazol-5-yl]oxypyridin-2-yl]acetamide; JAK inhibitor

Product Size

2 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CHZ868 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK2.

Molecular Weight

423.42

Molecular Formula

C₂₂H₁₉F₂N₅O₂

Targets

JAK2: 110 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

CHZ868 is employed to explore selective JAK2 inhibition and its applicability in treating myeloproliferative neoplasms.